Geri

INFLAMMATION INDICES PREDICT STENT THROMBOSIS IN GERIATRIC PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION

Article

Volume 29, Issue 3

September 2026 · Pages 285-295

INFLAMMATION INDICES PREDICT STENT THROMBOSIS IN GERIATRIC PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION

Habibe KAFES1, Bahar TEKİN TAK1, Anıl Can ERGÜN1, Özge Çakmak KARAASLAN1, Ahmet TEMİZHAN1, Firdevs Ayşenur EKİZLER1

1University of Health Sciences, Ankara City Hospital, 1. Department of Cardiology, Çankaya, Turkiye

DOI: 10.29400/tjgeri.2026.500

Keywords: Aged Biomarkers Inflammation Stent Thrombosis ST Elevation Myocardial Infarction

Introduction: The objective of this investigation was to determine whether the systemic immune-inflammation index (SII) and pan-immune-inflammation value (PIV), which serve as comprehensive indicators of systemic inflammatory pathways, possess the prognostic capacity to identify future stent thrombosis (ST) in geriatric STEMI patients.

Materials and Method: We comprehensively screened a consecutive cohort of 1,683 elderly individuals (aged 75.3 ± 6.8 years; 64.6% male) who had been treated with primary percutaneous coronary intervention (PCI) for acute ST-elevation myocardial infarction (STEMI). Stratification was performed based on the clinical manifestation of angiographically confirmed ST during follow-up. Both SII and PIV scores were computed from standard complete blood counts obtained at the time of initial clinical presentation.

Results: Over an average follow-up duration of 30 ± 10 months, definite ST was documented in 104 individuals (6.2%). Patients experiencing ST exhibited distinct baseline profiles, characterized by a higher prevalence of tobacco use and hypertension, a greater frequency of early dual antiplatelet therapy (DAPT) cessation (<30 days), prolonged total stent lengths, and markedly elevated baseline high-sensitivity C-reactive protein (hs-CRP), SII, and PIV levels. In multivariable Cox proportional hazards modeling, both admission PIV and SII emerged as robust, standalone indicators of subsequent ST. Furthermore, correlation analyses demonstrated that hs-CRP levels fluctuated in tandem with both SII (r=0.342, p<0.001) and PIV (r=0.268, p<0.001) values.

Conclusion: In summary, these data demonstrate that baseline immuno-inflammatory indices serve as independent and highly reliable indicators of subsequent ST development within the high-risk geriatric cohort treated with primary PCI for STEMI.